HANSEN BUYOUT ALERT – National Securities Law Firm Seeks Higher Price for Hansen Medical Shareholders in Connection with Proposed Buyout, and Encourages Shareholders to Contact Law Firm for More Information
April 20, 2016
New York, New York
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Hansen Medical, Inc. (NASDAQ: HNSN) (“Hansen” or the “Company”) on behalf of its shareholders. Hansen announced that it has entered into a definitive agreement to be acquired by Auris Surgical Robotics, Inc. for $4 per share. In addition, certain significant shareholders of Hansen have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
Our investigation has determined that the offer price of only $4 per share, unfairly under-values the true going forward inherent value of Hansen and that shareholders may not be receiving the maximum value for their shares. Indeed, the stock hit a high of $10.70 per share within the past year. The investigation further seeks to determine whether Hansen senior management is entering into this deal for its own self-interests to the detriment of the Company’s shareholders.
If you are a shareholder of Hansen and would like additional information as to how the proposed acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-511-7037 or contact us via our website or go to Participate in an Action.
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and has assisted in the recovery of billions of dollars for shareholders in securities actions around the globe.
Attorney advertising. Prior results do not indicate a similar outcome.